KennethLim personal page - To The Moon

KennethLim

KennethLim

No personal profile

35Follow

12Followers

0Topic

0Badge

01-02

$UMS(558.SI)$ like it ❣️

2025-09-17

$Golden Agri-Res(E5H.SI)$ here we go!!!

2025-09-12

$Golden Agri-Res(E5H.SI)$ like it [Cool]

2025-07-15

$Keppel DC Reit(AJBU.SI)$ yo!!!

2025-06-22

$Keppel DC Reit(AJBU.SI)$ ❤️

2025-06-16

$Keppel DC Reit(AJBU.SI)$ something I regularly invest in

2025-06-10

2025-06-08

$Frencken(E28.SI)$ semiconductor counter rat i investment in. Looking for good return....

2025-06-08

$Keppel DC Reit(AJBU.SI)$ :)

2025-03-21

$Keppel DC Reit(AJBU.SI)$ nice!!

2024-01-17

$Frencken(E28.SI)$

2023-12-13

$Frencken(E28.SI)$

2023-01-07

Ha!

China in Talks With Pfizer for Generic COVID Drug

2023-01-07

K

Sorry, the original content has been removed

2022-11-22

Ok

3 Stocks to Avoid This Week

2022-10-25

k

@TigerEvents:[REWARDS] How has your stock performed this year?

2022-09-28

Thanks

2022-09-15

$OVERSEA-CHINESE BANKING CORP(O39.SI)$i like ocbc with his stable income & dividend. Price is stable and not volatile. Good to keep for long term.

2022-09-14

$NIO Inc.(NIO.SI)$good run for Nio, from 18 to 21 & heading to 22

2022-09-13

$Apple(AAPL)$i didn't monitorvfor months & the price goes up for 10%!

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3573516985440152","uuid":"3573516985440152","gmtCreate":1610430742833,"gmtModify":1662610003668,"name":"KennethLim","pinyin":"kennethlim","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":12,"headSize":35,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":4,"name":"文化虎","nameTw":"文化虎","represent":"学有所成","factor":"发布30条非转发主帖,其中3条优质帖","iconColor":"8867FB","bgColor":"BDC5FF"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.02.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.55%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.12","exceedPercentage":"60.45%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"60.46%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":15,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":517301868310992,"gmtCreate":1767317407445,"gmtModify":1767317411109,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS(558.SI)$ </a> like it ❣️","listText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS(558.SI)$ </a> like it ❣️","text":"$UMS(558.SI)$ like it ❣️","images":[{"img":"https://community-static.tradeup.com/news/f1cd3bd62ced33eb2e2553b966fa12d6","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/517301868310992","isVote":1,"tweetType":1,"viewCount":439,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":479412428653392,"gmtCreate":1758070982542,"gmtModify":1758070986124,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E5H.SI\">$Golden Agri-Res(E5H.SI)$ </a> here we go!!!","listText":"<a href=\"https://ttm.financial/S/E5H.SI\">$Golden Agri-Res(E5H.SI)$ </a> here we go!!!","text":"$Golden Agri-Res(E5H.SI)$ here we go!!!","images":[{"img":"https://community-static.tradeup.com/news/76a72a7db3eb94cb91dd2ad373cf5469","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/479412428653392","isVote":1,"tweetType":1,"viewCount":1461,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":477831167648288,"gmtCreate":1757664301108,"gmtModify":1757664304373,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E5H.SI\">$Golden Agri-Res(E5H.SI)$ </a> like it&nbsp;[Cool]&nbsp;&nbsp;","listText":"<a href=\"https://ttm.financial/S/E5H.SI\">$Golden Agri-Res(E5H.SI)$ </a> like it&nbsp;[Cool]&nbsp;&nbsp;","text":"$Golden Agri-Res(E5H.SI)$ like it [Cool]","images":[{"img":"https://community-static.tradeup.com/news/120f65cd9ab0a7e200c1ac4a57a90456","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/477831167648288","isVote":1,"tweetType":1,"viewCount":1717,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":456805974589472,"gmtCreate":1752532963751,"gmtModify":1752532967797,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> yo!!!","listText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> yo!!!","text":"$Keppel DC Reit(AJBU.SI)$ yo!!!","images":[{"img":"https://community-static.tradeup.com/news/90a4f20ce22cd28025642daf5750ebc1","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/456805974589472","isVote":1,"tweetType":1,"viewCount":1807,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":448531591508416,"gmtCreate":1750526303933,"gmtModify":1750526307698,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> ❤️","listText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> ❤️","text":"$Keppel DC Reit(AJBU.SI)$ ❤️","images":[{"img":"https://community-static.tradeup.com/news/2b7c9280007003f29d877bce719cd32e","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/448531591508416","isVote":1,"tweetType":1,"viewCount":2369,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"10000000000010968","authorId":"10000000000010968","name":"Tiger_CashBoostAccount","avatar":"https://community-static.tradeup.com/news/ae2d4002ef9664aba005cb3020f416f5","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"10000000000010968","idStr":"10000000000010968"},"content":"Congratulations on your succeed trades. Your profits are a great reward for your hard work and strategic planning. Keep up the excellent investment decisions. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.🥳💹💰 Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here. Other helpful links: How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.","text":"Congratulations on your succeed trades. Your profits are a great reward for your hard work and strategic planning. Keep up the excellent investment decisions. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.🥳💹💰 Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here. Other helpful links: How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website.","html":"Congratulations on your succeed trades. Your profits are a great reward for your hard work and strategic planning. Keep up the excellent investment decisions. Trade with Tiger Cash Boost Account and use contra trading to enhance your strategies.🥳💹💰 Welcome to open a CBA today and enjoy access to a trading limit of up to SGD 20,000 with upcoming 0-commission, unlimited trading on SG, HK, and US stocks, as well as ETFs. Find out more here. Other helpful links: How to open a CBA. How to link your CDP account. Other FAQs on CBA. Cash Boost Account Website."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":446484255576416,"gmtCreate":1750029074075,"gmtModify":1750029078968,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> something I regularly invest in","listText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> something I regularly invest in","text":"$Keppel DC Reit(AJBU.SI)$ something I regularly invest in","images":[{"img":"https://community-static.tradeup.com/news/225973104274b97c03e009f8352c22a3","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/446484255576416","isVote":1,"tweetType":1,"viewCount":1598,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":444272079331432,"gmtCreate":1749489350385,"gmtModify":1749489354044,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS(558.SI)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS(558.SI)$ </a>&nbsp;","text":"$UMS(558.SI)$","images":[{"img":"https://community-static.tradeup.com/news/b5e093c70b843d26c75bd3889e544966","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/444272079331432","isVote":1,"tweetType":1,"viewCount":2841,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3581727244675977","authorId":"3581727244675977","name":"MySGX","avatar":"https://static.tigerbbs.com/f6a22f88deb287b757cb3e60419d2882","crmLevel":12,"crmLevelSwitch":0,"authorIdStr":"3581727244675977","idStr":"3581727244675977"},"content":"invested in ums for slightly more than 10 years. the dividends payout already received 150% of my capital. my unrealized profit is est 3x continue to collect dividends","text":"invested in ums for slightly more than 10 years. the dividends payout already received 150% of my capital. my unrealized profit is est 3x continue to collect dividends","html":"invested in ums for slightly more than 10 years. the dividends payout already received 150% of my capital. my unrealized profit is est 3x continue to collect dividends"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":443734981009448,"gmtCreate":1749346073648,"gmtModify":1749346077683,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a> semiconductor counter rat i investment in.&nbsp; Looking for good return....","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a> semiconductor counter rat i investment in.&nbsp; Looking for good return....","text":"$Frencken(E28.SI)$ semiconductor counter rat i investment in. Looking for good return....","images":[{"img":"https://community-static.tradeup.com/news/d1627058710c089ed38365e4ca6d51c7","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/443734981009448","isVote":1,"tweetType":1,"viewCount":2564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":443656887021584,"gmtCreate":1749345938476,"gmtModify":1749345942140,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> :)","listText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> :)","text":"$Keppel DC Reit(AJBU.SI)$ :)","images":[{"img":"https://community-static.tradeup.com/news/dc7096faf3c4cfea8ec6818228ed3b5e","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/443656887021584","isVote":1,"tweetType":1,"viewCount":1867,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":415702547005824,"gmtCreate":1742519016654,"gmtModify":1742519020808,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> nice!!","listText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> nice!!","text":"$Keppel DC Reit(AJBU.SI)$ nice!!","images":[{"img":"https://community-static.tradeup.com/news/d0d1188dbf2539809188be6f6779e531","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/415702547005824","isVote":1,"tweetType":1,"viewCount":2883,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":263853833371928,"gmtCreate":1705453103928,"gmtModify":1705453106955,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a>&nbsp;","text":"$Frencken(E28.SI)$","images":[{"img":"https://community-static.tradeup.com/news/96efe3c78fd28659b4688e50d9328648","width":"870","height":"1708"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/263853833371928","isVote":1,"tweetType":1,"viewCount":3482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":251461901549624,"gmtCreate":1702429277621,"gmtModify":1702429280415,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a>&nbsp;","text":"$Frencken(E28.SI)$","images":[{"img":"https://community-static.tradeup.com/news/b1ca05d8e617f01acd009bfbe5ab85d4","width":"870","height":"1708"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/251461901549624","isVote":1,"tweetType":1,"viewCount":2242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9959735123,"gmtCreate":1673065107762,"gmtModify":1676538783116,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"Ha!","listText":"Ha!","text":"Ha!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9959735123","repostId":"2301748452","repostType":4,"repost":{"id":"2301748452","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1673046905,"share":"https://ttm.financial/m/news/2301748452?lang=en_US&edition=fundamental","pubTime":"2023-01-07 07:15","market":"us","language":"en","title":"China in Talks With Pfizer for Generic COVID Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2301748452","media":"Reuters","summary":"HONG KONG/BEIJING, Jan 6 (Reuters) - China is in talks with Pfizer Inc to secure a licence that will","content":"<html><head></head><body><p>HONG KONG/BEIJING, Jan 6 (Reuters) - China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm&#39;s COVID-19 antiviral drug Paxlovid in China, three sources told Reuters.</p><p>China&#39;s medical products regulator - the National Medical Products Administration (NMPA) - has been leading the talks with Pfizer since late last month, one of the sources with knowledge of the matter said.</p><p>Beijing is keen to finalise licensing deal terms before the Lunar New Year which begins on Jan. 22, the source said.</p><p>Chinese hospitals are under intense pressure after the government abruptly abandoned its &#34;zero-COVID&#34; policy last month, sending infections soaring. The surging wave of infections across the country has overwhelmed hospitals, emptied pharmacies of medicines and caused international alarm.</p><p>Paxlovid, found to have reduced hospitalisations in high-risk patients by around 90% in a clinical trial, is in high demand with many Chinese attempting to get the drug abroad and have it shipped to China. Beijing has been largely resistant to western vaccines and treatments. Oral treatment Paxlovid is one of the few foreign ones it has approved.</p><p>In February last year, China approved Paxlovid, which was supposed to be largely available via hospitals, to treat high-risk patients in several provinces. Pfizer last month reached an agreement to export Paxlovid to China through a local company to make the medicine more widely available.</p><p>The NMPA and the State Council Information Office, which handles media queries for the government, did not respond to Reuters requests for comment.</p><p>A Pfizer spokesperson said the company is actively collaborating with Chinese authorities and all stakeholders to secure an adequate supply of Paxlovid in China.</p><p>All the sources declined to be identified as they are not authorised to speak to media.</p><p>The NMPA held a meeting with several Chinese drugmakers in late December to discuss preparations needed to make a generic version of Paxlovid hoping it would be able to secure the licence in the near future, two of the sources said.</p><p>Zhejiang Huahai Pharmaceutical, which signed a deal with Pfizer in August to produce Paxlovid only for use on the mainland, and CSPC Pharmaceutical Group, a developer of a potential mRNA COVID vaccine, are among those that attended the meeting, the first source said.</p><p>The second source said the NMPA has also advised firms to prepare to register with the regulator to produce the generic version of Paxlovid.</p><h2>GENERIC DRUGMAKERS</h2><p>Prospective candidates including Huahai and CSPC have in recent weeks been conducting &#34;bioequivalence tests&#34;, which are required by Chinese regulators before generic drugs can be launched, the two sources and another source with direct knowledge of the matter said.</p><p>For a generic drug to be deemed equivalent to a branded medicine, such tests are required to make sure they work the same way in the body.</p><p>Both Huahai and CSPC expect to submit the tests results to the NMPA later this month, one of them added.</p><p>Huahai and CSPC did not respond to a request for comment.</p><p>In March, 35 generic drugmakers around the world including five Chinese firms agreed to make cheap versions of Paxlovid for 95 poorer countries through a licensing arrangement with the U.N.-backed Medicines Patent Pool (MPP). That licence does not allow the companies to sell generic Paxlovid in China.</p><p>The MPP licensing arrangement is royalty free for Pfizer, while COVID-19 remains classified as a &#34;Public Health Emergency of International Concern&#34; by the World Health Organization (WHO).</p><p>Following the pandemic period, sales to low-income countries will remain royalty free, lower-middle-income countries and upper-middle-income countries will be subject to a 5% royalty for sales to the public sector and a 10% royalty for sales to the private sector, MPP said at that time.</p><p>Due to severe shortages of antivirals as 1.4 billion Chinese battle infections, many have turned to underground channels to secure Paxlovid and other drugs, according to domestic media. Scalpers charge as much as 50,000 yuan ($7,260) for a box of Paxlovid, more than 20 times its original price of 2,300 yuan.</p><p>China has also pressed Pfizer to lower the price of Paxlovid as the government aims to include the drug in the national medical insurance scheme which could cover part of the cost, the three sources said.</p><p>($1 = 6.8875 Chinese yuan)</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China in Talks With Pfizer for Generic COVID Drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina in Talks With Pfizer for Generic COVID Drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-01-07 07:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>HONG KONG/BEIJING, Jan 6 (Reuters) - China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm&#39;s COVID-19 antiviral drug Paxlovid in China, three sources told Reuters.</p><p>China&#39;s medical products regulator - the National Medical Products Administration (NMPA) - has been leading the talks with Pfizer since late last month, one of the sources with knowledge of the matter said.</p><p>Beijing is keen to finalise licensing deal terms before the Lunar New Year which begins on Jan. 22, the source said.</p><p>Chinese hospitals are under intense pressure after the government abruptly abandoned its &#34;zero-COVID&#34; policy last month, sending infections soaring. The surging wave of infections across the country has overwhelmed hospitals, emptied pharmacies of medicines and caused international alarm.</p><p>Paxlovid, found to have reduced hospitalisations in high-risk patients by around 90% in a clinical trial, is in high demand with many Chinese attempting to get the drug abroad and have it shipped to China. Beijing has been largely resistant to western vaccines and treatments. Oral treatment Paxlovid is one of the few foreign ones it has approved.</p><p>In February last year, China approved Paxlovid, which was supposed to be largely available via hospitals, to treat high-risk patients in several provinces. Pfizer last month reached an agreement to export Paxlovid to China through a local company to make the medicine more widely available.</p><p>The NMPA and the State Council Information Office, which handles media queries for the government, did not respond to Reuters requests for comment.</p><p>A Pfizer spokesperson said the company is actively collaborating with Chinese authorities and all stakeholders to secure an adequate supply of Paxlovid in China.</p><p>All the sources declined to be identified as they are not authorised to speak to media.</p><p>The NMPA held a meeting with several Chinese drugmakers in late December to discuss preparations needed to make a generic version of Paxlovid hoping it would be able to secure the licence in the near future, two of the sources said.</p><p>Zhejiang Huahai Pharmaceutical, which signed a deal with Pfizer in August to produce Paxlovid only for use on the mainland, and CSPC Pharmaceutical Group, a developer of a potential mRNA COVID vaccine, are among those that attended the meeting, the first source said.</p><p>The second source said the NMPA has also advised firms to prepare to register with the regulator to produce the generic version of Paxlovid.</p><h2>GENERIC DRUGMAKERS</h2><p>Prospective candidates including Huahai and CSPC have in recent weeks been conducting &#34;bioequivalence tests&#34;, which are required by Chinese regulators before generic drugs can be launched, the two sources and another source with direct knowledge of the matter said.</p><p>For a generic drug to be deemed equivalent to a branded medicine, such tests are required to make sure they work the same way in the body.</p><p>Both Huahai and CSPC expect to submit the tests results to the NMPA later this month, one of them added.</p><p>Huahai and CSPC did not respond to a request for comment.</p><p>In March, 35 generic drugmakers around the world including five Chinese firms agreed to make cheap versions of Paxlovid for 95 poorer countries through a licensing arrangement with the U.N.-backed Medicines Patent Pool (MPP). That licence does not allow the companies to sell generic Paxlovid in China.</p><p>The MPP licensing arrangement is royalty free for Pfizer, while COVID-19 remains classified as a &#34;Public Health Emergency of International Concern&#34; by the World Health Organization (WHO).</p><p>Following the pandemic period, sales to low-income countries will remain royalty free, lower-middle-income countries and upper-middle-income countries will be subject to a 5% royalty for sales to the public sector and a 10% royalty for sales to the private sector, MPP said at that time.</p><p>Due to severe shortages of antivirals as 1.4 billion Chinese battle infections, many have turned to underground channels to secure Paxlovid and other drugs, according to domestic media. Scalpers charge as much as 50,000 yuan ($7,260) for a box of Paxlovid, more than 20 times its original price of 2,300 yuan.</p><p>China has also pressed Pfizer to lower the price of Paxlovid as the government aims to include the drug in the national medical insurance scheme which could cover part of the cost, the three sources said.</p><p>($1 = 6.8875 Chinese yuan)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SG9999002232.USD":"Allianz Global High Payout USD","PFE":"辉瑞","BK4581":"高盛持仓","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","SG9999002224.SGD":"Allianz Global High Payout SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4585":"ETF&股票定投概念","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4124":"机动车零配件与设备","BK4534":"瑞士信贷持仓","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","BK4533":"AQR资本管理(全球第二大对冲基金)","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU0122379950.USD":"贝莱德世界健康科学A2","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","LU0234572021.USD":"高盛美国核心股票组合Acc","LU0058720904.USD":"联博国际健康护理基金A","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓","SG9999001176.USD":"United Global Healthcare Acc USD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4007":"制药","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2301748452","content_text":"HONG KONG/BEIJING, Jan 6 (Reuters) - China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm's COVID-19 antiviral drug Paxlovid in China, three sources told Reuters.China's medical products regulator - the National Medical Products Administration (NMPA) - has been leading the talks with Pfizer since late last month, one of the sources with knowledge of the matter said.Beijing is keen to finalise licensing deal terms before the Lunar New Year which begins on Jan. 22, the source said.Chinese hospitals are under intense pressure after the government abruptly abandoned its \"zero-COVID\" policy last month, sending infections soaring. The surging wave of infections across the country has overwhelmed hospitals, emptied pharmacies of medicines and caused international alarm.Paxlovid, found to have reduced hospitalisations in high-risk patients by around 90% in a clinical trial, is in high demand with many Chinese attempting to get the drug abroad and have it shipped to China. Beijing has been largely resistant to western vaccines and treatments. Oral treatment Paxlovid is one of the few foreign ones it has approved.In February last year, China approved Paxlovid, which was supposed to be largely available via hospitals, to treat high-risk patients in several provinces. Pfizer last month reached an agreement to export Paxlovid to China through a local company to make the medicine more widely available.The NMPA and the State Council Information Office, which handles media queries for the government, did not respond to Reuters requests for comment.A Pfizer spokesperson said the company is actively collaborating with Chinese authorities and all stakeholders to secure an adequate supply of Paxlovid in China.All the sources declined to be identified as they are not authorised to speak to media.The NMPA held a meeting with several Chinese drugmakers in late December to discuss preparations needed to make a generic version of Paxlovid hoping it would be able to secure the licence in the near future, two of the sources said.Zhejiang Huahai Pharmaceutical, which signed a deal with Pfizer in August to produce Paxlovid only for use on the mainland, and CSPC Pharmaceutical Group, a developer of a potential mRNA COVID vaccine, are among those that attended the meeting, the first source said.The second source said the NMPA has also advised firms to prepare to register with the regulator to produce the generic version of Paxlovid.GENERIC DRUGMAKERSProspective candidates including Huahai and CSPC have in recent weeks been conducting \"bioequivalence tests\", which are required by Chinese regulators before generic drugs can be launched, the two sources and another source with direct knowledge of the matter said.For a generic drug to be deemed equivalent to a branded medicine, such tests are required to make sure they work the same way in the body.Both Huahai and CSPC expect to submit the tests results to the NMPA later this month, one of them added.Huahai and CSPC did not respond to a request for comment.In March, 35 generic drugmakers around the world including five Chinese firms agreed to make cheap versions of Paxlovid for 95 poorer countries through a licensing arrangement with the U.N.-backed Medicines Patent Pool (MPP). That licence does not allow the companies to sell generic Paxlovid in China.The MPP licensing arrangement is royalty free for Pfizer, while COVID-19 remains classified as a \"Public Health Emergency of International Concern\" by the World Health Organization (WHO).Following the pandemic period, sales to low-income countries will remain royalty free, lower-middle-income countries and upper-middle-income countries will be subject to a 5% royalty for sales to the public sector and a 10% royalty for sales to the private sector, MPP said at that time.Due to severe shortages of antivirals as 1.4 billion Chinese battle infections, many have turned to underground channels to secure Paxlovid and other drugs, according to domestic media. Scalpers charge as much as 50,000 yuan ($7,260) for a box of Paxlovid, more than 20 times its original price of 2,300 yuan.China has also pressed Pfizer to lower the price of Paxlovid as the government aims to include the drug in the national medical insurance scheme which could cover part of the cost, the three sources said.($1 = 6.8875 Chinese yuan)","news_type":1,"symbols_score_info":{"PFE":1}},"isVote":1,"tweetType":1,"viewCount":2308,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9959735976,"gmtCreate":1673065098195,"gmtModify":1676538783109,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9959735976","repostId":"1199658349","repostType":4,"isVote":1,"tweetType":1,"viewCount":2114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9968020335,"gmtCreate":1669079289627,"gmtModify":1676538148147,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/9968020335","repostId":"2285904055","repostType":4,"repost":{"id":"2285904055","kind":"highlight","pubTimestamp":1669089004,"share":"https://ttm.financial/m/news/2285904055?lang=en_US&edition=fundamental","pubTime":"2022-11-22 11:50","market":"us","language":"en","title":"3 Stocks to Avoid This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2285904055","media":"Motley Fool","summary":"These investments seem pretty vulnerable right now.","content":"<div>\n<p>Last week was a letdown for investors long the market after a strong rally the week before. The \"three stocks to avoid\" in my column that I thought were going to lose to the market last week -- ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/11/21/3-stocks-to-avoid-this-week/\">Source Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Avoid This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Avoid This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-11-22 11:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/11/21/3-stocks-to-avoid-this-week/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Last week was a letdown for investors long the market after a strong rally the week before. The \"three stocks to avoid\" in my column that I thought were going to lose to the market last week -- ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/11/21/3-stocks-to-avoid-this-week/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","BBY":"百思买","LKNCY":"瑞幸咖啡"},"source_url":"https://www.fool.com/investing/2022/11/21/3-stocks-to-avoid-this-week/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2285904055","content_text":"Last week was a letdown for investors long the market after a strong rally the week before. The \"three stocks to avoid\" in my column that I thought were going to lose to the market last week -- Coinbase, Despegar.com, and Bowlero -- fell 21%, 12%, and 12%, respectively, averaging out to a 15% plunge.The S&P 500 experienced only a 0.7% move lower. I was right. I have been correct in 36 of the past 57 weeks, or 63% of the time.Now let's look at the week ahead. I see Best Buy, Luckin Coffee, and Apple as stocks you might want to consider steering clear of this week. Let's go over my near-term concerns with all three investments.1. Best BuyBest Buy's revival a few years ago was a thing of beauty. Now we're seeing that the last major consumer-electronics superstore chain still standing is on wobbly legs.The retailer reports fresh financials on Tuesday morning, and it won't be pretty. Analysts see revenue clocking in 13% lower than the prior-year's fiscal third quarter. Its profit is expected to be cut in half.The near-term outlook is uninspiring. Wall Street pros see revenue slipping 11% for the current holiday quarter, as well as the entire fiscal 2023 year that ends in January. Profitability should take a bigger hit. If you're buying Best Buy for that chunky 4.9% yield, that's a dicey proposition when its bottom line is going the wrong way.Rising costs and the inability of a brick-and-mortar chain to compete on price with bare-boned online merchants are making life hard for Best Buy, again. Now we have a potentially dimming economy setting back demand for consumer electronics.To be fair, Best Buy's renaissance wasn't that exciting. You have to go back to fiscal 2009 -- 14 years -- to find the last time that this chain delivered top-line gains in the double digits.2. Luckin CoffeeIf you were to construct the perfect stock to avoid in a lab, it would probably look a lot like Luckin Coffee. It's a China-based company at a time when most investors outside of the country are steering clear of the market.Let's also not forget that Luckin Coffee is a stock that -- like its hot java -- already burned investors before. You surely remember the accounting scandal of 2020.Have you checked on Luckin Coffee stock lately? The stock is a 20-bagger off its C-suite drama low. The shares ended this past week within 0.5% of a new two-year high, nearly quadrupling from this-year's springtime bottom. We'll get an update on how it's brewing when it pours a cup of third-quarter results on Tuesday.Luckin Coffee has done a commendable job turning things around. After years of losses, it was profitable in 2021. Revenue continued to grow.However, Luckin Coffee's top-line gains have decelerated for four consecutive quarters. It also posted a loss in its previous quarter. It's hard to get excited about Luckin Coffee. It may seem like a low-priced indulgence, but it's a luxury that consumers will avoid if they need to save their money for more-pressing expenses.3. AppleLet's wrap-up this-week's list by picking on the country's most valuable company by market cap. I'm a longtime fan and investor in Apple, but I can see why it's a scary stock to hold heading into this particular holiday shopping season. The economy is on iffy footing, credit card debit is rising, and Apple isn't going to be immune from consumers steering clear of big-ticket purchases this season.Apple held up well when most tech stocks got slammed earlier this year, but the class act of Cupertino is finally proving mortal. It doesn't help that its annual refresh of popular products wasn't overly impressive. With money already tight, it's easy to see consumers ride this year out and see what Apple springs on us in 2023.Analysts aren't excited. They see revenue and earnings per share rising a mere 3% and 2%, respectively, for the new fiscal year.It's going to be a bumpy road for some of these investments. If you're looking for safe stocks, you aren't likely to find them in Best Buy, Luckin Coffee, and Apple this week.","news_type":1,"symbols_score_info":{"AAPL":0.9,"LKNCY":0.9,"BBY":0.9}},"isVote":1,"tweetType":1,"viewCount":2402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9988141116,"gmtCreate":1666705240836,"gmtModify":1676537793002,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"k","listText":"k","text":"k","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9988141116","repostId":"9988149248","repostType":1,"repost":{"id":9988149248,"gmtCreate":1666704929585,"gmtModify":1676537792709,"author":{"id":"3527667667103859","authorId":"3527667667103859","name":"TigerEvents","avatar":"https://community-static.tradeup.com/news/c266ef25181ace18bec1262357bbe1a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3527667667103859","idStr":"3527667667103859"},"themes":[],"title":"[REWARDS] How has your stock performed this year?","htmlText":"Hi Tigers:I would like to invite you to share your positions and to win Tiger Coins.Sharing positions is simple. From your account holdings interface, you can click \"Share\" by each of your stock holdings to discuss with the community how much money you have made (or lost) on your investments.Due to the Fed's recent increase in interest rates, many stocks have fallen, particularly the technology sector, which has entered the \"discounting season\" early this year.&nbsp;The share prices of<a href=\"https://ttm.financial/S/GOOG\">$Alphabet(GOOG)$</a> and<a href=\"https://ttm.financial/S/AMZN\">$Amazon.com(AMZN)$</a> have fallen more than 30% so far this year. The share prices of <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a> have fallen more than 40% so far this year.","listText":"Hi Tigers:I would like to invite you to share your positions and to win Tiger Coins.Sharing positions is simple. From your account holdings interface, you can click \"Share\" by each of your stock holdings to discuss with the community how much money you have made (or lost) on your investments.Due to the Fed's recent increase in interest rates, many stocks have fallen, particularly the technology sector, which has entered the \"discounting season\" early this year.&nbsp;The share prices of<a href=\"https://ttm.financial/S/GOOG\">$Alphabet(GOOG)$</a> and<a href=\"https://ttm.financial/S/AMZN\">$Amazon.com(AMZN)$</a> have fallen more than 30% so far this year. The share prices of <a href=\"https://ttm.financial/S/TSLA\">$Tesla Motors(TSLA)$</a> have fallen more than 40% so far this year.","text":"Hi Tigers:I would like to invite you to share your positions and to win Tiger Coins.Sharing positions is simple. From your account holdings interface, you can click \"Share\" by each of your stock holdings to discuss with the community how much money you have made (or lost) on your investments.Due to the Fed's recent increase in interest rates, many stocks have fallen, particularly the technology sector, which has entered the \"discounting season\" early this year. The share prices of$Alphabet(GOOG)$ and$Amazon.com(AMZN)$ have fallen more than 30% so far this year. The share prices of $Tesla Motors(TSLA)$ have fallen more than 40% so far this year.","images":[{"img":"https://static.tigerbbs.com/b403c20c141980924fa878bf76a65edc","width":"-1","height":"-1"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9988149248","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"subType":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":2332,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9918343175,"gmtCreate":1664327123597,"gmtModify":1676537433232,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9918343175","isVote":1,"tweetType":1,"viewCount":2029,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9934117776,"gmtCreate":1663204159795,"gmtModify":1676537226395,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>i like ocbc with his stable income &amp; dividend. Price is stable and not volatile. Good to keep for long term.","listText":"<a href=\"https://ttm.financial/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>i like ocbc with his stable income &amp; dividend. Price is stable and not volatile. Good to keep for long term.","text":"$OVERSEA-CHINESE BANKING CORP(O39.SI)$i like ocbc with his stable income & dividend. Price is stable and not volatile. Good to keep for long term.","images":[{"img":"https://community-static.tradeup.com/news/f1c5139ba2b781ed3ce599b8d286dcf5","width":"1080","height":"2672"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":9,"repostSize":0,"link":"https://ttm.financial/post/9934117776","isVote":1,"tweetType":1,"viewCount":3232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9935435409,"gmtCreate":1663120190001,"gmtModify":1676537208095,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NIO.SI\">$NIO Inc.(NIO.SI)$</a>good run for Nio, from 18 to 21 &amp; heading to 22","listText":"<a href=\"https://ttm.financial/S/NIO.SI\">$NIO Inc.(NIO.SI)$</a>good run for Nio, from 18 to 21 &amp; heading to 22","text":"$NIO Inc.(NIO.SI)$good run for Nio, from 18 to 21 & heading to 22","images":[{"img":"https://community-static.tradeup.com/news/1c3153a4810cf824c1e36ec6afcbe29a","width":"1080","height":"2672"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9935435409","isVote":1,"tweetType":1,"viewCount":2063,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9935951126,"gmtCreate":1663028492866,"gmtModify":1676537184953,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>i didn't monitorvfor months &amp; the price goes up for 10%!","listText":"<a href=\"https://ttm.financial/S/AAPL\">$Apple(AAPL)$</a>i didn't monitorvfor months &amp; the price goes up for 10%!","text":"$Apple(AAPL)$i didn't monitorvfor months & the price goes up for 10%!","images":[{"img":"https://community-static.tradeup.com/news/70a6ba79b86bc1ff0af5b5dbc24ed4a4","width":"1080","height":"2233"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9935951126","isVote":1,"tweetType":1,"viewCount":1754,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":9023070238,"gmtCreate":1652840920024,"gmtModify":1676535173322,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"title":"FRENCKEN Group","htmlText":"Frencken: FRENCKEN Group’s net profit fell 12.6 per cent year-on-year to S$12.8 million in Q1 due to higher costs and heightened supply chain challenges in the second half of FY2021.“Higher prices of materials, freight and energy in 1QFY22 compared to 1QFY21 have driven up input costs and the group is working on cost mitigation actions,” the mainboard-listed company said in a business update on Tuesday (May 17).Revenue went up 9.3 per cent year-on-year to S$198.4 million, driven primarily by double digit sales of the group’s mechatronics division, which accounted for 87.1 per cent of the manufacturer’s revenue in Q1.","listText":"Frencken: FRENCKEN Group’s net profit fell 12.6 per cent year-on-year to S$12.8 million in Q1 due to higher costs and heightened supply chain challenges in the second half of FY2021.“Higher prices of materials, freight and energy in 1QFY22 compared to 1QFY21 have driven up input costs and the group is working on cost mitigation actions,” the mainboard-listed company said in a business update on Tuesday (May 17).Revenue went up 9.3 per cent year-on-year to S$198.4 million, driven primarily by double digit sales of the group’s mechatronics division, which accounted for 87.1 per cent of the manufacturer’s revenue in Q1.","text":"Frencken: FRENCKEN Group’s net profit fell 12.6 per cent year-on-year to S$12.8 million in Q1 due to higher costs and heightened supply chain challenges in the second half of FY2021.“Higher prices of materials, freight and energy in 1QFY22 compared to 1QFY21 have driven up input costs and the group is working on cost mitigation actions,” the mainboard-listed company said in a business update on Tuesday (May 17).Revenue went up 9.3 per cent year-on-year to S$198.4 million, driven primarily by double digit sales of the group’s mechatronics division, which accounted for 87.1 per cent of the manufacturer’s revenue in Q1.","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":29,"commentSize":0,"repostSize":2,"link":"https://ttm.financial/post/9023070238","isVote":1,"tweetType":1,"viewCount":1812,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9028085509,"gmtCreate":1653117509501,"gmtModify":1676535227775,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E5H.SI\">$GOLDEN AGRI-RESOURCES LTD(E5H.SI)$</a>no more banned of indo export that create an up movement now... how high can it go?","listText":"<a href=\"https://ttm.financial/S/E5H.SI\">$GOLDEN AGRI-RESOURCES LTD(E5H.SI)$</a>no more banned of indo export that create an up movement now... how high can it go?","text":"$GOLDEN AGRI-RESOURCES LTD(E5H.SI)$no more banned of indo export that create an up movement now... how high can it go?","images":[{"img":"https://community-static.tradeup.com/news/3ba209c693aa5badae8902a8e65f08e7","width":"1080","height":"1920"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":30,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9028085509","isVote":1,"tweetType":1,"viewCount":1453,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9023069216,"gmtCreate":1652837488735,"gmtModify":1676535172186,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$FRENCKEN GROUP LIMITED(E28.SI)$</a>Frencken: FRENCKEN Group’s net profit fell 12.6 per cent year-on-year to S$12.8 million in Q1 due to higher costs and heightened supply chain challenges in the second half of FY2021.“Higher prices of materials, freight and energy in 1QFY22 compared to 1QFY21 have driven up input costs and the group is working on cost mitigation actions,” the mainboard-listed company said in a business update on Tuesday (May 17).Revenue went up 9.3 per cent year-on-year to S$198.4 million, driven primarily by double digit sales of the group’s mechatronics division, which accounted for 87.1 per cent of the manufacturer’s revenue in Q1.","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$FRENCKEN GROUP LIMITED(E28.SI)$</a>Frencken: FRENCKEN Group’s net profit fell 12.6 per cent year-on-year to S$12.8 million in Q1 due to higher costs and heightened supply chain challenges in the second half of FY2021.“Higher prices of materials, freight and energy in 1QFY22 compared to 1QFY21 have driven up input costs and the group is working on cost mitigation actions,” the mainboard-listed company said in a business update on Tuesday (May 17).Revenue went up 9.3 per cent year-on-year to S$198.4 million, driven primarily by double digit sales of the group’s mechatronics division, which accounted for 87.1 per cent of the manufacturer’s revenue in Q1.","text":"$FRENCKEN GROUP LIMITED(E28.SI)$Frencken: FRENCKEN Group’s net profit fell 12.6 per cent year-on-year to S$12.8 million in Q1 due to higher costs and heightened supply chain challenges in the second half of FY2021.“Higher prices of materials, freight and energy in 1QFY22 compared to 1QFY21 have driven up input costs and the group is working on cost mitigation actions,” the mainboard-listed company said in a business update on Tuesday (May 17).Revenue went up 9.3 per cent year-on-year to S$198.4 million, driven primarily by double digit sales of the group’s mechatronics division, which accounted for 87.1 per cent of the manufacturer’s revenue in Q1.","images":[{"img":"https://community-static.tradeup.com/news/f339a24169edf49c049c5fc0638925dc","width":"1080","height":"3642"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":22,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/9023069216","isVote":1,"tweetType":1,"viewCount":2006,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9905365528,"gmtCreate":1659832285366,"gmtModify":1703766791899,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$FRENCKEN GROUP LIMITED(E28.SI)$</a>this seems to be back to 2020 level... will it shut up to sgd2 again?&nbsp;","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$FRENCKEN GROUP LIMITED(E28.SI)$</a>this seems to be back to 2020 level... will it shut up to sgd2 again?&nbsp;","text":"$FRENCKEN GROUP LIMITED(E28.SI)$this seems to be back to 2020 level... will it shut up to sgd2 again?","images":[{"img":"https://community-static.tradeup.com/news/5fdf68a698b1ee7e650adc77e0ef1714","width":"1080","height":"2492"}],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":18,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9905365528","isVote":1,"tweetType":1,"viewCount":786,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9064933855,"gmtCreate":1652263233877,"gmtModify":1676535064100,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"title":"<<ums-come on>>","htmlText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>UMS Holdings net profit rises 26% in Q1 2022 driven by semiconductor demandMAINBOARD-LISTED precision-engineering company net profit for the first quarter ended Mar 31, 2022 rose 26 per cent year on year to S$19.4 million from S$15.4 million previously.It also announced an interim dividend of 1 Singapore cent per share for the quarter ended March 31.","listText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>UMS Holdings net profit rises 26% in Q1 2022 driven by semiconductor demandMAINBOARD-LISTED precision-engineering company net profit for the first quarter ended Mar 31, 2022 rose 26 per cent year on year to S$19.4 million from S$15.4 million previously.It also announced an interim dividend of 1 Singapore cent per share for the quarter ended March 31.","text":"$UMS HOLDINGS LIMITED(558.SI)$UMS Holdings net profit rises 26% in Q1 2022 driven by semiconductor demandMAINBOARD-LISTED precision-engineering company net profit for the first quarter ended Mar 31, 2022 rose 26 per cent year on year to S$19.4 million from S$15.4 million previously.It also announced an interim dividend of 1 Singapore cent per share for the quarter ended March 31.","images":[],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9064933855","isVote":1,"tweetType":1,"viewCount":717,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"9000000000000525","authorId":"9000000000000525","name":"JuliusGoldsmith","avatar":"https://static.tigerbbs.com/aa7cf122cebf5a413a760f20bd5fed89","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"9000000000000525","idStr":"9000000000000525"},"content":"a slightly low level dividend","text":"a slightly low level dividend","html":"a slightly low level dividend"},{"author":{"id":"9000000000000616","authorId":"9000000000000616","name":"Tracccy","avatar":"https://static.tigerbbs.com/6f69266757bb8aeff3ab26b6e6df27f7","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"9000000000000616","idStr":"9000000000000616"},"content":"Thanks for sharing. It got great profit.","text":"Thanks for sharing. It got great profit.","html":"Thanks for sharing. It got great profit."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9064081695,"gmtCreate":1652247578617,"gmtModify":1676535061720,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>UMS Holdings net profit rises 26% in Q1 2022 driven by semiconductor demandMAINBOARD-LISTED precision-engineering company net profit for the first quarter ended Mar 31, 2022 rose 26 per cent year on year to S$19.4 million from S$15.4 million previously.It also announced an interim dividend of 1 Singapore cent per share for the quarter ended March 31.","listText":"<a href=\"https://ttm.financial/S/558.SI\">$UMS HOLDINGS LIMITED(558.SI)$</a>UMS Holdings net profit rises 26% in Q1 2022 driven by semiconductor demandMAINBOARD-LISTED precision-engineering company net profit for the first quarter ended Mar 31, 2022 rose 26 per cent year on year to S$19.4 million from S$15.4 million previously.It also announced an interim dividend of 1 Singapore cent per share for the quarter ended March 31.","text":"$UMS HOLDINGS LIMITED(558.SI)$UMS Holdings net profit rises 26% in Q1 2022 driven by semiconductor demandMAINBOARD-LISTED precision-engineering company net profit for the first quarter ended Mar 31, 2022 rose 26 per cent year on year to S$19.4 million from S$15.4 million previously.It also announced an interim dividend of 1 Singapore cent per share for the quarter ended March 31.","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":12,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9064081695","isVote":1,"tweetType":1,"viewCount":990,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9938037559,"gmtCreate":1662520139872,"gmtModify":1676537079545,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a>SSG border is open yet the results of Genting is not improvement.... what's next?","listText":"<a href=\"https://ttm.financial/S/G13.SI\">$GENTING SINGAPORE LIMITED(G13.SI)$</a>SSG border is open yet the results of Genting is not improvement.... what's next?","text":"$GENTING SINGAPORE LIMITED(G13.SI)$SSG border is open yet the results of Genting is not improvement.... what's next?","images":[{"img":"https://community-static.tradeup.com/news/4bf5bc4377f76edc7a73d1d0e2a52727","width":"1080","height":"2489"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":16,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/9938037559","isVote":1,"tweetType":1,"viewCount":1372,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9934117776,"gmtCreate":1663204159795,"gmtModify":1676537226395,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>i like ocbc with his stable income &amp; dividend. Price is stable and not volatile. Good to keep for long term.","listText":"<a href=\"https://ttm.financial/S/O39.SI\">$OVERSEA-CHINESE BANKING CORP(O39.SI)$</a>i like ocbc with his stable income &amp; dividend. Price is stable and not volatile. Good to keep for long term.","text":"$OVERSEA-CHINESE BANKING CORP(O39.SI)$i like ocbc with his stable income & dividend. Price is stable and not volatile. Good to keep for long term.","images":[{"img":"https://community-static.tradeup.com/news/f1c5139ba2b781ed3ce599b8d286dcf5","width":"1080","height":"2672"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":9,"repostSize":0,"link":"https://ttm.financial/post/9934117776","isVote":1,"tweetType":1,"viewCount":3232,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":415702547005824,"gmtCreate":1742519016654,"gmtModify":1742519020808,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> nice!!","listText":"<a href=\"https://ttm.financial/S/AJBU.SI\">$Keppel DC Reit(AJBU.SI)$ </a> nice!!","text":"$Keppel DC Reit(AJBU.SI)$ nice!!","images":[{"img":"https://community-static.tradeup.com/news/d0d1188dbf2539809188be6f6779e531","width":"870","height":"1772"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/415702547005824","isVote":1,"tweetType":1,"viewCount":2883,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":263853833371928,"gmtCreate":1705453103928,"gmtModify":1705453106955,"author":{"id":"3573516985440152","authorId":"3573516985440152","name":"KennethLim","avatar":"https://community-static.tradeup.com/news/b14c36aded4c09af72784800119db550","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573516985440152","idStr":"3573516985440152"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a>&nbsp;","listText":"<a href=\"https://ttm.financial/S/E28.SI\">$Frencken(E28.SI)$ </a>&nbsp;","text":"$Frencken(E28.SI)$","images":[{"img":"https://community-static.tradeup.com/news/96efe3c78fd28659b4688e50d9328648","width":"870","height":"1708"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/263853833371928","isVote":1,"tweetType":1,"viewCount":3482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}